Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EB103 |
Trade Name | |
Synonyms | EB 103|EB-103 |
Drug Descriptions |
Limited information is currently available on EB103, a putative CD19-targeted T-cell therapy (Aug 2024). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
EB103 | EB103 | 0 | 1 |